ABIOMED, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1981-01-01
- Employees
- 2K
- Market Cap
- -
- Website
- http://www.abiomed.com
RECOVER I Impella RECOVER LP/LD 5.0 Support System Safety and Feasibility Study
Phase 2
Completed
- Conditions
- Cardiac Surgery
- First Posted Date
- 2008-01-17
- Last Posted Date
- 2010-05-27
- Lead Sponsor
- Abiomed Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT00596726
- Locations
- 🇺🇸
University of Maryland, Baltimore, Maryland, United States
🇺🇸Massach General Hospital, Boston, Massachusetts, United States
🇺🇸Hershey Medical Center, Hershey, Pennsylvania, United States
Protect II, A Prospective, Multicenter Randomized Controlled Trial
Phase 3
Terminated
- Conditions
- Coronary Artery Disease
- Interventions
- Device: IMPLELLA LP 2.5Device: IABP Intra-aortic balloon pump
- First Posted Date
- 2007-11-21
- Last Posted Date
- 2011-03-21
- Lead Sponsor
- Abiomed Inc.
- Target Recruit Count
- 452
- Registration Number
- NCT00562016
- Locations
- 🇺🇸
Emory Crawford Long Hospital, Atlanta, Georgia, United States
🇺🇸Loyola University Medical Center, Maywood, Illinois, United States
🇺🇸Bryan LGH Heart Institute, Lincoln, Nebraska, United States
PROTECT I, A Prospective Feasibility Trial Investigating the Use of IMPELLA RECOVER LP 2.5 System in Patients Undergoing High Risk PCI
Phase 2
Completed
- Conditions
- Patients Undergoing High Risk PCI.
- First Posted Date
- 2007-09-26
- Last Posted Date
- 2011-03-21
- Lead Sponsor
- Abiomed Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT00534859
- Locations
- 🇺🇸
William Beaumont, Royal Oak, Michigan, United States
🇺🇸UPMC Presbyterian Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸Cedars-Sinai Medical Center, Los Angeles, California, United States
© Copyright 2025. All Rights Reserved by MedPath